Web Exclusives

Thumbnail image for The rise of virtual pharma

The rise of virtual pharma

The rise of virtual business models in biopharma reflects the changing face of the pharmaceutical industry - big pharma discovering and developing its own pipeline exclusively in-house no longer exists.

11th February 2019

Thumbnail image for Medical devices regulation countdown

Medical devices regulation countdown

Cliodhna McDonough says new regulations on the horizon for medical devices in Europe present a huge challenge to manufacturers, but could also deliver improved confidence in the consistency and effectiveness of the regulatory process.

11th February 2019

Thumbnail image for The SPC eligibility issue

The SPC eligibility issue

The European Court should prepare for legal challenges to the ineligibility of new medical technologies for Supplementary Protection Certificates (SPCs).

23rd January 2019

Thumbnail image for Redefining Value

Redefining Value

In today’s highly competitive healthcare market how can pharma companies stand out from the crowd? Showing brand value has never been more important.

23rd January 2019

Thumbnail image for The controversy over gene-editing

The controversy over gene-editing

CRISPR has the potential to transform a variety of scientific areas, but this genome editing technique is also shrouded in controversy, particularly regarding its potential use to create genetically engineered humans.

10th January 2019

Thumbnail image for Unlocking sci-tech growth in the UK

Unlocking sci-tech growth in the UK

The health of the life sciences sector in 2019 will continue to be a major focus as the UK navigates all the issues surrounding Brexit.

7th January 2019

Thumbnail image for Tackling temperature excursions

Tackling temperature excursions

Saddam Huq, global QA senior manager, Distribution & Cold Chain, at GlaxoSmithKline, speaks to PharmaTimes about temperature excursions and managing the associated risks on a global scale.

7th January 2019

Thumbnail image for Winning the battle for tech talent

Winning the battle for tech talent

Excitement around the transformative potential of AI and machine learning continues to build. Companies will need to adapt their individual offers to draw in AI specialists, but as an industry UK pharma should also continue to champion itself and the unique career advantages it holds for the best and brightest researchers.

12th December 2018

Thumbnail image for NIHR welcomes Life Sciences Sector Deal 2

NIHR welcomes Life Sciences Sector Deal 2

Professor Chris Whitty, chief scientific adviser for the Department of Health and Social Care (DHSC), on the role of the NIHR and the promise of the government's second sector deal for the life sciences industry.

6th December 2018

Thumbnail image for Adapting to the challenge

Adapting to the challenge

Mark Toms, chief scientific officer at Novartis Pharmaceuticals UK, looks at how to address the challenges of recruiting for Alzheimer’s prevention studies.

6th December 2018

Thumbnail image for Orphan drug development and the urgent need for a new approach

Orphan drug development and the urgent need for a new approach

There are around 7,000 rare diseases for which there currently exists no authorised or satisfactory method of treatment, highlighting a vast area of unmet need, and yet the clinical development of orphan drugs is still fraught with many practical challenges.

5th December 2018

Previous  --   1 2 3 4 5 6 7   --  Next

Latest jobs

View all

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download